30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Vivakor Inc (VIVK)

Track

Stock chart
Ticker: VIVK Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Ballengee James H.
Chairman, President, & CEO
1 purchase — total 1,570 USD
Buy 3 Jun 2024
Value US$4,705,746.00 | Price 77.06 | Shares 88,178
Buy 31 May 2024
Value US$1,921,809.23 | Price 171.29 | Shares 63,551
Buy 30 May 2024
Value US$23,064.27 | Price 1.52 | Shares 15,139
Buy 29 May 2024
Value US$56,731.26 | Price 1.35 | Shares 42,098
Buy 28 May 2024
Value US$20,929.49 | Price 1.37 | Shares 15,277
Buy 24 May 2024
Value US$52,553.87 | Price 1.27 | Shares 41,381
Buy 23 May 2024
Value US$39,659.76 | Price 1.29 | Shares 30,744
Buy 24 Apr 2024
Value US$75,525.00 | Price 1.59 | Shares 47,500
Buy 24 Apr 2024
Value US$75,525.00 | Price 1.59 | Shares 47,500
Buy 23 Apr 2024
Value US$78,480.00 | Price 1.44 | Shares 54,500
Buy 23 Apr 2024
Value US$78,480.00 | Price 1.44 | Shares 54,500
Buy 22 Apr 2024
Value US$189,060.00 | Price 1.37 | Shares 138,000
Buy 19 Apr 2024
Value US$33,600.00 | Price 1.12 | Shares 30,000
Buy 23 Feb 2022
Value US$0.00 | Price 0.00 | Shares 3,528
Buy 17 Feb 2022
Value US$944.00 | Price 2.95 | Shares 320
Buy 16 Feb 2022
Value US$944.00 | Price 2.95 | Shares 320
Sale 17 Feb 2010
Value US$24,750.00 | Price 0.03 | Shares 825,000
Buy 7 Oct 2009
Value US$1,767.50 | Price 0.51 | Shares 3,500
Buy 6 Oct 2009
Value US$1,680.00 | Price 0.48 | Shares 3,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-06 2024-06-03 B Purchase
3.5
Ballengee James H.

Chairman, President, & CEO

Executive Director Large shareholder
88,178 -5.6%
77.06
US$4,705,746 		88,178 -5.6% 77.06 US$4,705,746
2024-08-06 2024-05-31 B Purchase
3.5
Ballengee James H.

Chairman, President, & CEO

Executive Director Large shareholder
63,551 -44.8%
171.29
US$1,921,809 		63,551 -44.8% 171.29 US$1,921,809
2024-08-06 2024-05-30 B Purchase
3.5
Ballengee James H.

Chairman, President, & CEO

Executive Director Large shareholder
28,184 -18.5%
197.43
US$4,746,284 		28,184 -18.5% 197.43 US$4,746,284
2024-08-06 2024-05-29 B Purchase
3.5
Ballengee James H.

Chairman, President, & CEO

Executive Director Large shareholder
42,098 +0.4%
1.35
US$56,731 		42,098 +0.4% 1.35 US$56,731
2024-05-29 2024-05-28 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
15,277 +1.1%
1.37
US$20,929 		15,277 +1.1% 1.37 US$20,929
2024-05-29 2024-05-24 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
41,381 +3.1%
1.27
US$52,554 		41,381 +3.1% 1.27 US$52,554
2024-05-29 2024-05-23 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
30,744 +2.4%
1.29
US$39,660 		30,744 +2.4% 1.29 US$39,660
2024-04-25 2024-04-24 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
47,500 +3.8%
1.59
US$75,525 		47,500 +3.8% 1.59 US$75,525
2024-04-25 2024-04-24 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
47,500 +3.8%
1.59
US$75,525 		47,500 +3.8% 1.59 US$75,525
2024-04-25 2024-04-23 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
54,500 +4.6%
1.44
US$78,480 		54,500 +4.6% 1.44 US$78,480
2024-04-25 2024-04-23 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
54,500 +4.6%
1.44
US$78,480 		54,500 +4.6% 1.44 US$78,480
2024-04-23 2024-04-22 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
138,000 +13.1%
1.37
US$189,060 		138,000 +13.1% 1.37 US$189,060
2024-04-23 2024-04-19 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
30,000 +2.9%
1.12
US$33,600 		30,000 +2.9% 1.12 US$33,600
2022-02-25 2022-02-23 B Purchase
0.9
Nicosia Matthew

Chief Executive Officer

Executive Director Large shareholder
3,528
0.00
US$0 		3,528 0.00 US$0
2022-02-24 2022-02-17 B Purchase
0.9
Nicosia Matthew

Chief Executive Officer

Executive Director Large shareholder
320 +0.0%
2.95
US$944 		320 +0.0% 2.95 US$944
2022-02-18 2022-02-16 B Purchase
0.9
Nicosia Matthew

Chief Executive Officer

Executive Director Large shareholder
320 +0.0%
2.95
US$944 		320 +0.0% 2.95 US$944
2010-02-19 2010-02-17 S Sale NFG, Inc. Large shareholder
825,000 -3.8%
0.03
US$24,750 		825,000 -3.8% 0.03 US$24,750
2009-10-07 2009-10-07 B Purchase NFG, Inc. Large shareholder
3,500 +0.0%
0.51
US$1,768 		3,500 +0.0% 0.51 US$1,768
2009-10-07 2009-10-06 B Purchase NFG, Inc. Large shareholder
3,500 +0.0%
0.48
US$1,680 		3,500 +0.0% 0.48 US$1,680
Explore more

More insider trading research around Vivakor Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America